Amass is a scientific intelligence platform for R&D and business development teams in biotech and pharma. We help teams evaluate scientific claims, map competitive landscapes, and make better decisions across pipelines and external opportunities. The platform analyzes publications, patents, clinical trials, regulatory data, and internal sources such as ELNs and company datasets to generate structured, evidence-based insights. Common use cases include: • Scientific due diligence • Pipeline and target evaluation • Competitive intelligence • Literature review and evidence synthesis Used by teams across pharma, biotech, and life science investors. Available as SaaS, API, and enterprise integrations into internal R&D workflows.
| Website | https://www.amass.tech/ |
| Employees | 9 (7 on RocketReach) |
| Founded | 2022 |
| Industry | Software Development |
| Keywords | Bioscience, Scientific Research, Scientific Knowledge, Research Data Management, Knowledge Management, Biotechnology, Scientific Data, Research Platform, Knowledge Discovery, Data Analysis, Research Intelligence, Information Retrieval, Data Integration, Scientific Collaboration, Data Sharing, Pharmaceutical Research, Big Data Analytics, Drug Discovery, Clinical Research |
| Competitors | Dun & Bradstreet, Kroll, Chainalysis, Trm, Elliptic, Ciphertrace, a Mastercard company, Crystal Blockchain Analytics, Prysm Media Group, Blockseer, AMLT +41 more (view full list) |
Looking for a particular amass employee's phone or email?
Henrik Jensen is the Co-Founder and CEO of amass.
7 people are employed at amass.